Antibody tests for identification of current and past infection with SARS‐CoV‐2
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Saliva as a candidate for COVID-19 diagnostic testing: a meta-analysis
Background: COVID-19 is a serious and potentially deadly disease. Early diagnosis of
infected individuals will play an important role in stop** its further escalation. The present …
infected individuals will play an important role in stop** its further escalation. The present …
False negative rate of COVID-19 PCR testing: a discordant testing analysis
JN Kanji, N Zelyas, C MacDonald, K Pabbaraju… - Virology journal, 2021 - Springer
Background COVID-19 is diagnosed via detection of SARS-CoV-2 RNA using real time
reverse-transcriptase polymerase chain reaction (rtRT-PCR). Performance of many SARS …
reverse-transcriptase polymerase chain reaction (rtRT-PCR). Performance of many SARS …
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva
N Pisanic, PR Randad, K Kruczynski… - Journal of clinical …, 2020 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of an ongoing
pandemic that has infected over 36 million and killed over 1 million people. Informed …
pandemic that has infected over 36 million and killed over 1 million people. Informed …
COVID‐19 clinical diagnostics and testing technology
CH Chau, JD Strope, WD Figg - Pharmacotherapy: The Journal …, 2020 - Wiley Online Library
Given the global nature of the coronavirus disease 2019 (COVID‐19) pandemic, the need
for disease detection and expanding testing capacity remains critical priorities. This review …
for disease detection and expanding testing capacity remains critical priorities. This review …
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
The global coronavirus disease 2019 (COVID-19) has presented major challenges for
clinical laboratories, from initial diagnosis to patient monitoring and treatment. Initial …
clinical laboratories, from initial diagnosis to patient monitoring and treatment. Initial …
Diagnosing COVID‐19 in the emergency department: a sco** review of clinical examinations, laboratory tests, imaging accuracy, and biases
Objective Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) emerged as a
global pandemic in early 2020 with rapidly evolving approaches to diagnosing the clinical …
global pandemic in early 2020 with rapidly evolving approaches to diagnosing the clinical …
[HTML][HTML] Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19
A Varadhachary, D Chatterjee, J Garza, RP Garr… - MedRxiv, 2020 - ncbi.nlm.nih.gov
Background: Mucosal immunity, including secretory IgA (sIgA), plays an important role in
early defenses against respiratory pathogens. Salivary testing, the most convenient way to …
early defenses against respiratory pathogens. Salivary testing, the most convenient way to …
COVID-19 salivary signature: diagnostic and research opportunities
The COVID-19 (caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2))
epidemic started in Wuhan (Hubei Province, China) in mid-December 2019 and quickly …
epidemic started in Wuhan (Hubei Province, China) in mid-December 2019 and quickly …
SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis
A Aita, D Basso, AM Cattelan, P Fioretto, F Navaglia… - Clinica chimica acta, 2020 - Elsevier
Aim This study aims to verify whether standardized saliva collection is suitable for SARS-
CoV-2 molecular detection and IgA measurement. Methods 43 COVID-19 inpatients and …
CoV-2 molecular detection and IgA measurement. Methods 43 COVID-19 inpatients and …